Up a level |
Jones, Robert ORCID: 0000-0001-5608-001X, Plummer, Ruth ORCID: 0000-0003-0107-1444, Moreno, Victor ORCID: 0000-0001-6099-4236, Carter, Louise ORCID: 0000-0002-9854-2304, Roda, Desamparados ORCID: 0000-0003-2657-9623, Garralda, Elena ORCID: 0000-0002-4412-7842, Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias ORCID: 0000-0002-2015-1549, Roxburgh, Patricia ORCID: 0000-0001-9869-591X et al (show 6 more authors)
(2023)
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 29 (2).
pp. 331-340.